Intranasal Oxytocin Attenuates Reactive and Ongoing, Chronic Pain in a Model of Mild Traumatic Brain Injury.

Anders C MeidahlAndreas EisenriedMichael KlukinovLonghui CaoAlexander Z TzabazisDavid C Yeomans

Published in: Headache (2017)

Intranasal oxytocin attenuates measures of reactive and non-reactive pain in a model of mild TBI and may represent a novel treatment for chronic pain in TBI patients.

Keyphrases

chronic pain
mild traumatic brain injury
traumatic brain injury
pain management
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
severe traumatic brain injury
patient reported outcomes
patient reported
neuropathic pain
replacement therapy